Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer


17th International Conference on Nephrology & Urology

London, UK

Simon Allen

Simon Allen

Fine Treatment, UK

Title: Thermobalancing therapy® and Dr Allen's Devices as an innovative treatment for prostate enlargement, chronic prostatitis and kidney stones


Biography: Simon Allen


Thermobalancing therapy® (TT) and Dr Allen’s therapeutic devices (DATD) provide a side effects free treatment for common chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and DATD received a US patent as “Therapeutic device and method”. 

TT is based on a new understanding of the origin of diseases that states that all chronic internal diseases have the same root, the pathological activity of capillaries. As a result of changes in small blood vessels, the focus of hypothermia becomes a continuous trigger in the affected tissue, which gradually increases the pressure in the affected organ that leads to its malfunction.


Therapeutic device applies a natural thermoelement, which accumulates the body heat, to the projection of the affected organ eliminating the focus of hypothermia. For prostate problems thermoelement must be applied to the coccyx area and to dissolve kidney stones 2 thermoelements - to the projection of kidneys. Dr Allen’s Device is a class 1 medical device, so it can be used by everyone at home.

Two clinical trials on TT confirmed its effectiveness. After 6-month use of DATD in 124 men with BPH, the prostate volume (mL) decreased from 45.1 to 31.8 and urinary symptoms score - from 14.3 to 4.7. In men with chronic prostatitis, after 6-month use of DATD pain reduction ranged from 10.3 to 3.5, and prostate volume (mL) from 31.7 to 27.0. There were no changes in the control groups. Thus, TT is an effective tool for urological conditions.